one8zero8 LLC Makes New Investment in Waters Co. (NYSE:WAT)

one8zero8 LLC purchased a new stake in shares of Waters Co. (NYSE:WAT - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The fund purchased 4,150 shares of the medical instruments supplier's stock, valued at approximately $1,540,000.

A number of other institutional investors have also added to or reduced their stakes in the stock. Natixis Advisors LLC grew its stake in shares of Waters by 11.1% during the fourth quarter. Natixis Advisors LLC now owns 156,614 shares of the medical instruments supplier's stock worth $58,101,000 after buying an additional 15,622 shares during the last quarter. Catalyst Funds Management Pty Ltd bought a new stake in Waters during the 4th quarter worth $594,000. Aviso Financial Inc. increased its holdings in Waters by 20.9% in the 4th quarter. Aviso Financial Inc. now owns 5,451 shares of the medical instruments supplier's stock worth $2,022,000 after purchasing an additional 941 shares in the last quarter. LBP AM SA bought a new position in Waters in the fourth quarter valued at about $2,138,000. Finally, Madison Investment Advisors LLC acquired a new stake in shares of Waters during the fourth quarter valued at about $104,645,000. 94.01% of the stock is currently owned by institutional investors and hedge funds.

Waters Trading Down 1.2 %

Shares of NYSE:WAT traded down $4.67 during mid-day trading on Wednesday, hitting $377.48. The company had a trading volume of 47,396 shares, compared to its average volume of 435,776. The company has a debt-to-equity ratio of 1.14, a current ratio of 0.94 and a quick ratio of 0.65. Waters Co. has a one year low of $279.24 and a one year high of $423.56. The firm has a fifty day moving average price of $391.36 and a 200 day moving average price of $370.97. The company has a market capitalization of $22.43 billion, a PE ratio of 35.36, a price-to-earnings-growth ratio of 3.79 and a beta of 1.00.

Remove Ads

Waters (NYSE:WAT - Get Free Report) last posted its quarterly earnings results on Wednesday, February 12th. The medical instruments supplier reported $4.10 earnings per share for the quarter, beating the consensus estimate of $4.02 by $0.08. Waters had a net margin of 21.56% and a return on equity of 46.31%. As a group, research analysts forecast that Waters Co. will post 12.86 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on WAT shares. JPMorgan Chase & Co. raised their price objective on shares of Waters from $380.00 to $390.00 and gave the company a "neutral" rating in a report on Thursday, March 6th. Barclays raised shares of Waters from an "underweight" rating to an "equal weight" rating and raised their price target for the company from $360.00 to $415.00 in a research note on Monday, February 10th. Sanford C. Bernstein raised shares of Waters from a "market perform" rating to an "outperform" rating and set a $430.00 price objective on the stock in a research note on Friday, January 10th. UBS Group raised their target price on Waters from $405.00 to $410.00 and gave the stock a "neutral" rating in a research report on Thursday, February 13th. Finally, Wells Fargo & Company upped their price target on Waters from $415.00 to $420.00 and gave the company an "overweight" rating in a research report on Thursday, February 13th. Eleven investment analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus price target of $391.07.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.